Literature DB >> 2199031

No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers.

T Victor1, R Du Toit, A M Jordaan, A J Bester, P D van Helden.   

Abstract

The molecular mechanisms underlying the induction of esophageal and gastric cancer are not yet understood. It is possible that different etiological factors from geographically distinct areas play a role in the onset of these cancers. Twenty-seven primary esophageal and 11 gastric cancers originating from the high-incidence areas of South Africa were analyzed for the presence of ras protooncogene mutations. We found no evidence for mutations in codons 12, 13, or 61 or the H-ras, K-ras, and N-ras genes in these primary cancers. Our results indicate that etiological factors such as fungal contamination of basic foodstuffs in a high-incidence area for these cancers do not play a role in the activation of ras genes and that mutations in these genes are not directly involved in the development of primary esophageal and gastric cancers in the South African population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199031

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions.

Authors:  Jian Li; Chang-Wei Feng; Zhi-Guo Zhao; Qi Zhou; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

2.  The role of ras gene mutation in gastric cancer and precancerous lesions.

Authors:  Y Hao; J Zhang; Y Lu; C Yi; W Qian; J Cui
Journal:  J Tongji Med Univ       Date:  1998

3.  Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.

Authors:  S J Meltzer; J Yin; Y Huang; T K McDaniel; C Newkirk; O Iseri; B Vogelstein; J H Resau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.

Authors:  R F Boynton; P L Blount; J Yin; V L Brown; Y Huang; Y Tong; T McDaniel; C Newkirk; J H Resau; W H Raskind; R C Haggitt; B J Reid; S J Meltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.

Authors:  J J O'Leary; R J Landers; I Silva; V Uhlmann; M Crowley; I Healy; K Luttich
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

6.  Loss of heterozygosity and K-ras gene mutations in gastric cancer.

Authors:  G N Ranzani; B Renault; N S Pellegata; P Fattorini; E Magni; F Bacci; D Amadori
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

7.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.

Authors:  W Jiang; Y J Zhang; S M Kahn; M C Hollstein; R M Santella; S H Lu; C C Harris; R Montesano; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 8.  Helicobacter and gastric cancer disease mechanisms: host response and disease susceptibility.

Authors:  Hanchen Li; Calin Stoicov; Xun Cai; Timothy C Wang; JeanMarie Houghton
Journal:  Curr Gastroenterol Rep       Date:  2003-12

9.  Absence of ras gene mutations in early gastric carcinomas.

Authors:  M E Craanen; P Blok; B Top; L Boerrigter; W Dekker; G J Offerhaus; G N Tytgat; S Rodenhuis
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

10.  Frequent K-ras mutations in small bowel adenocarcinomas.

Authors:  T Sutter; N Arber; S F Moss; R I Findling; A I Neugut; I B Weinstein; P R Holt
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.